17.75
-0.13 (-0.73%)
| 前收盘价格 | 17.88 |
| 收盘价格 | 17.73 |
| 成交量 | 3,313 |
| 平均成交量 (3个月) | 8,990 |
| 市值 | 227,469,792 |
| 市盈率 (P/E TTM) | 14.67 |
| 价格/销量 (P/S) | 4.66 |
| 股市价格/股市净资产 (P/B) | 0.820 |
| 52周波幅 | |
| 利润日期 | 8 Aug 2023 - 14 Aug 2023 |
| 营业毛利率 | 50.30% |
| 营业利益率 (TTM) | 66.68% |
| 稀释每股收益 (EPS TTM) | 1.41 |
| 季度收入增长率 (YOY) | 153.10% |
| 季度盈利增长率 (YOY) | 869.90% |
| 总债务/股东权益 (D/E MRQ) | 11.00% |
| 流动比率 (MRQ) | 45.85 |
| 营业现金流 (OCF TTM) | 26.90 M |
| 资产报酬率 (ROA TTM) | 5.37% |
| 股东权益报酬率 (ROE TTM) | 6.13% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Asset Management (US) | 混合的 | 混合的 |
| Asset Management (全球的) | 混合的 | 混合的 | |
| 股票 | SWK Holdings Corporation | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -3.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.0 |
| 平均 | 0.06 |
|
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |
|
| 部门 | Financial Services |
| 行业 | Asset Management |
| 投资方式 | Small Value |
| 内部持股比例 | 6.38% |
| 机构持股比例 | 87.34% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合